CONTACT
OVER 10 YEARS EXPERIENCE

Office

Paasheuvelweg 25, Wing C5

1105BP Amsterdam

info@acsbiomarker.com

Laboratory

IWO, 3rd floor, Lab IA.3-192

Meibergdreef 39

1105 AZ Amsterdam

+31 (20) 56 65 458

info@acsbiomarker.com

  • LinkedIn Social Icon
  • Twitter Social Icon

Technotes, Publications, Technology platforms and FAQs

 

Publications and Technotes

ACS Biomarker aims to advance translational research by publishing high-quality data in peer reviewed journals. See our technotes for details on our measurement and analysis pipeline.

Publications

Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients.

Bayés-Genis A. et al. Eur J Heart Fail. 2017 Sep 26

Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure.

van Boven N. et al. Eur J Heart Fail. 2017 Sep 26

Circulating miRNA Analysis Guidelines

De Ronde et al. RNA. 2017 May;23(5):811-821

miR-22-3p in heart failure

Van Boven et al. Int J Cardiol. 2017 May 15;235:124-132

MiR423-5p as a circulating biomarker for heart failure.

Tijsen et al. Circ Res. 2010 Apr 2;106(6):1035-9. 

Exosome Extractions

Sample submission

Sample preparation

Cardio-Onco Biomarker Panel

miRNA profiling

TECHNOLOGY PLATFORMS

RNA profiling platform

To obtain high quality results we have chosen the superior miRNA platform of Quantabio for our biomarker services. This platform offers a cost-effective method to measure multiple RNA molecules from a single RT reaction. The open technology provides flexibility to design your own assay primers and eliminates inefficient stem-loop priming and costly hydrolysis probes. It has been reported as one of the best miRNA profiling platforms and guarantees to deliver reliable results.